Active	Status	Sponsor type	Region	Phase	Filter
1 Active 96 Inactive 97 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   - « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Cerebral Small Vessel Diseases
NCT01476163: Physician Initiated Expanded Access Request for Migalastat in Individual Patients With Fabry Disease	Available	N/A		US, RoW	migalastat HCl 150 mg, AT1001, migalastat, migalastat HCl 20 mg	Amicus Therapeutics	Fabry Disease

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Cerebral Small Vessel Diseases
NCT01476163: Physician Initiated Expanded Access Request for Migalastat in Individual Patients With Fabry Disease	Available	N/A		US, RoW	migalastat HCl 150 mg, AT1001, migalastat, migalastat HCl 20 mg	Amicus Therapeutics	Fabry Disease